Skip to content

Discontinued — last reported Q4 '21

Geographic · D&A

Americas Orthopedics — D&A

Zimmer Biomet Holdings Americas Orthopedics — D&A remained flat by 0.0% to $35.78M in Q4 2021 compared to the prior quarter.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2021Feb 25, 2022
Rolls up toD&A

How to read this metric

An increase often reflects recent capital investments in manufacturing or R&D, while a decrease may suggest aging assets or reduced investment in the segment's infrastructure.

Detailed definition

This represents the non-cash allocation of the cost of tangible assets and the systematic write-off of intangible assets...

Peer comparison

Standard across all capital-intensive manufacturing industries; comparable to segment-level D&A in medical device peers.

Metric ID: zbh_segment_americas_orthopedics_depreciation_and_amortization

Historical Data

1 years
 FY'21
Value$143.1M

Frequently Asked Questions

What is Zimmer Biomet Holdings's americas orthopedics — d&a?
Zimmer Biomet Holdings (ZBH) reported americas orthopedics — d&a of $35.78M in Q4 2021.
What does americas orthopedics — d&a mean?
The portion of asset costs recognized as an expense for the Americas Orthopedics segment during the period.